NO820201L - Fremgangsmaate til fremstilling av nye n-substituerte polyglycidyl-urazolforbindelser - Google Patents

Fremgangsmaate til fremstilling av nye n-substituerte polyglycidyl-urazolforbindelser

Info

Publication number
NO820201L
NO820201L NO820201A NO820201A NO820201L NO 820201 L NO820201 L NO 820201L NO 820201 A NO820201 A NO 820201A NO 820201 A NO820201 A NO 820201A NO 820201 L NO820201 L NO 820201L
Authority
NO
Norway
Prior art keywords
residue
urazole
reaction
residues
glycidyl
Prior art date
Application number
NO820201A
Other languages
English (en)
Norwegian (no)
Inventor
Herbert Fischer
Brigitte Hase
Hinrich Moeller
Hans-Christoph Wilk
Ulrich Zeidler
Original Assignee
Henkel Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel Kgaa filed Critical Henkel Kgaa
Publication of NO820201L publication Critical patent/NO820201L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Resins (AREA)
  • Phenolic Resins Or Amino Resins (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO820201A 1981-01-24 1982-01-22 Fremgangsmaate til fremstilling av nye n-substituerte polyglycidyl-urazolforbindelser NO820201L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813102373 DE3102373A1 (de) 1981-01-24 1981-01-24 "neue n-substituierte polyglycidyl-urazolverbindungen, verfahren zu ihrer herstellung sowie pharmzeutische zubereitungen

Publications (1)

Publication Number Publication Date
NO820201L true NO820201L (no) 1982-07-26

Family

ID=6123305

Family Applications (1)

Application Number Title Priority Date Filing Date
NO820201A NO820201L (no) 1981-01-24 1982-01-22 Fremgangsmaate til fremstilling av nye n-substituerte polyglycidyl-urazolforbindelser

Country Status (21)

Country Link
US (1) US4801601A (es)
EP (1) EP0056962B1 (es)
JP (1) JPS57142982A (es)
KR (1) KR880001106B1 (es)
AT (1) ATE15898T1 (es)
AU (1) AU548803B2 (es)
CA (1) CA1197847A (es)
CS (1) CS252809B2 (es)
DD (1) DD202025A5 (es)
DE (2) DE3102373A1 (es)
DK (1) DK27882A (es)
ES (1) ES508992A0 (es)
FI (1) FI71934C (es)
HU (1) HU189557B (es)
IE (1) IE51930B1 (es)
IL (1) IL64844A (es)
NO (1) NO820201L (es)
NZ (1) NZ199485A (es)
PL (1) PL135459B1 (es)
SU (2) SU1118287A3 (es)
ZA (1) ZA82451B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3330640A1 (de) * 1983-08-25 1985-03-14 Henkel KGaA, 4000 Düsseldorf Verfahren zur addition von saeuren an glycidylverbindungen
DE3336693A1 (de) * 1983-10-08 1985-04-25 Henkel KGaA, 4000 Düsseldorf Antitumormittel
WO2012050591A1 (en) 2010-10-15 2012-04-19 Rutgers, The State University Of New Jersey Hydrogel formulation for dermal and ocular delivery
US20090104254A1 (en) 2004-12-22 2009-04-23 Rutgers, The State University Of New Jersey Controlled Release Hydrogels

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2935354A1 (de) * 1979-09-01 1981-03-19 Bayer Ag, 5090 Leverkusen Triglycidyl-triazolidin-3,5-dione und verfahren zu ihrer herstellung
ATE22080T1 (de) * 1980-01-31 1986-09-15 Henkel Kgaa Arzneimittel mit cytostatischer wirkung sowie verwendung von mehrfach mit glycidylgruppen substituierten n-heterocyclischen ringverbindungen in pharmazeutischen zubereitungen.
DE3027623A1 (de) * 1980-07-21 1982-02-18 Bayer Ag, 5090 Leverkusen Neue glycidyl-1,2,4-triazolidin-3,5-dione und ein verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
KR830009063A (ko) 1983-12-17
SU1118287A3 (ru) 1984-10-07
ES8302695A1 (es) 1982-12-01
ATE15898T1 (de) 1985-10-15
IL64844A (en) 1986-10-31
IE51930B1 (en) 1987-04-29
CS252809B2 (en) 1987-10-15
ES508992A0 (es) 1982-12-01
FI71934B (fi) 1986-11-28
AU7974382A (en) 1982-08-05
EP0056962B1 (de) 1985-10-02
ZA82451B (en) 1982-12-29
PL234828A1 (en) 1983-04-11
EP0056962A3 (en) 1982-08-25
IE820133L (en) 1982-07-24
AU548803B2 (en) 1986-01-02
NZ199485A (en) 1984-05-31
EP0056962A2 (de) 1982-08-04
DK27882A (da) 1982-07-25
CS50782A2 (en) 1986-12-18
DD202025A5 (de) 1983-08-24
IL64844A0 (en) 1982-03-31
CA1197847A (en) 1985-12-10
DE3266588D1 (en) 1985-11-07
FI820201L (fi) 1982-07-25
SU1074405A3 (ru) 1984-02-15
DE3102373A1 (de) 1982-08-26
FI71934C (fi) 1987-03-09
JPS57142982A (en) 1982-09-03
HU189557B (en) 1986-07-28
KR880001106B1 (ko) 1988-06-29
US4801601A (en) 1989-01-31
PL135459B1 (en) 1985-10-31

Similar Documents

Publication Publication Date Title
AU2019346118B2 (en) Manufacture of compounds and compositions for inhibiting the activity of SHP2
US4393060A (en) Isocyanuric acid derivatives, method of preparation, therapeutic compositions with a cytostatic action and therapeutic method
DE68911417T2 (de) Cyclohexan-Derivate.
JPH0649697B2 (ja) 放射線治療または化学療法に有用な化合物
NO820201L (no) Fremgangsmaate til fremstilling av nye n-substituerte polyglycidyl-urazolforbindelser
NO155880B (no) Analogifremgangsmaate til fremstilling av terapeutisk aktivt 2-(2'hydroksy-3'-(1,1-dimetylpropylamino)-propoksy)-beta-fenylpropionfenon.
US4376120A (en) Therapeutic compositions with a cytostatic action containing isocyanuric acid derivatives and process of manufacture
WO1998052551A1 (fr) Composes bisaryle et remedes contre le cancer contenant ces composes
JPS6058747B2 (ja) アミノ化合物の製法
Kim et al. Synthesis and antileukemic activity of 2-(2-methylthio-2-aminovinyl)-1-methylquinolinium iodides
FI61871C (fi) Analogifoerfarande foer framstaellning av antidepressivt verkande trifluormetylsubstituerade aralkylestrar av alanin
CA1179266A (en) Isocyanuric acid derivatives, method of preparation, therapeutic compositions with a cytostatic action and therapeutic method
AU2021222332A1 (en) Macrocyclic indole derivatives as inhibitors of MCL-1
CS212669B1 (en) Basic esters of the 7-oxo-7h-benzo/c/fluorene and method of preparation thereof
Gleiter et al. A [1, 2] and a [1, 4] shift in a Wittig thioether rearrangement. Isolation of a [1.1](2, 8) naphthalenophane tautomer
JPS5829785A (ja) 新規ジグリシジル−プテリジン化合物、その製造法、及びこれを含有し細胞静止作用を有する薬剤調合物
CS202007B2 (en) Method of producing aminoderivatives of 4-hydroxy-1,2-benzoisothiazole
JPH049386A (ja) 6H―チオピラノ[3,2―d]ピリミジン誘導体およびその製造法
JPS6293272A (ja) ピペラジン誘導体及びその製法
FR2570376A1 (fr) Nouveaux (isopropyl-5 (((methoxy-2 phenyl) piperazinyl)-2 ethoxy)-4 methyl-2 phenoxy)-1 alkylamino-3 propanols-2, leur methode de preparation et leur application therapeutique
JPS62116568A (ja) チアゾリジン誘導体及びその製法
PL98225B1 (pl) Sposob wytwarzania nowych pochodnych 1-fenoksy-2-hydroksy-3-aminopropanu